Grant RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• Adult Life Predictors of Genitourinary Disorders
• Adult Life Predictors of Genitourinary Disorders
• Adult Life Predictors of Genitourinary Disorders
• Adult Offender Reentry Program
• Adult Stem Cell Therapy in Humanized Mouse Models of Anemia
• Advanced Austempered Ductile Iron
• Advanced CO2 Leakage Mitigation Using Engineered Biomineralization Sealing Technologies
• Advanced Education Nurse Traineeship Program
• Advanced Education Nursing Grants
• Advanced Education Nursing Grants
• Advanced Education Nursing Traineeship (AENT) Program
• Advanced Education Nursing Traineeship (AENT) Program
• Advanced Education Nursing Traineeship Program
• Advanced Education Nursing Traineeship Program
• Advanced Hazmat Life Support Toxic Terrorism Course
• Advanced Hazmat Life Toxic Terrorism Support Course
• Advanced Illness and Multimorbidity (AIM) Research Program
• Advanced Nursing Education Grants
• Advanced Technology to Study Visual Function on a Cellular Scale
• Advances in Perinatal Education in 2015
• Advancing a Formal Multidisciplinary Surgical Simulation Curriculum through High Fidelity Laparoscopic Simulation
• Advancing B.Sc. in Engineering Students in Hybrid-Electric and Electric Vehicles
• Advancing Health Equity
• Advancing Health Equity in Jefferson County II
• Advancing Health Equity in Jefferson County, AL
• Advancing PINK1 KO Rat Animal Models of PD
• Advancing PINK1 KO Rat Animal Models of PD
• Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Project 1 & 2
• ADVL 1515: A Phase 1 Study of LY2606368, A CHK 1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, Including CNS Tumors
• ADVL 1615: A phase 1 Study of Pevonedistat (MLN4924), A Cullin Ligase Inhibitor, In Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refactory Solid Tumors

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...